Es mostra/en per Autor Verdaguer, Helena
Es mostren els resultats 1 a 3 de 3
| Data de publicació | Títol | Autor(s) |
|---|---|---|
| 9-oct-2024 | Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial | Fullana, Bartomeu; Morales, Serafín; Petit, Anna; Alay, Ania; Verdaguer, Helena; Climent, Fina; Navarro Perez, Valentí; Cejuela, Mónica; Galvan, Patricia; Gumà, Anna; Llombart Cussac, Antonio; Cordero, David; Casanovas, Oriol; Prat Aparicio, Aleix; Gil Gil, Miguel; Pernas, Sònia |
| 1-març-2022 | Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors | Garcia Carbonero, Rocio; Bazan Peregrino, Miriam; Gil Martin, Marta; Álvarez, Rafael; Macarulla, Teresa; Riesco Martinez, Maria C.; Verdaguer, Helena; Guillén Ponce, Carmen; Farrera Sal, Martí; Moreno, Rafael; Mato Berciano, Ana; Maliandi, Maria Victoria; Torres Manjon, Silvia; Costa, Marcel; Pozo, Natalia del; Martínez de Villarreal, Jaime; Real, Francisco X.; Vidal, Noemí; Capella, Gabriel; Alemany Bonastre, Ramon; Blasi, Emma; Blasco, Carmen; Cascallò, Manel; Salazar Soler, Ramón |
| 10-jul-2020 | Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice | Laquente, Berta; Macarulla, Teresa; Buges, Cristina; Martin, Marta; Garcia, Carlos; Pericay, Carles; Merino, Sandra; Visa, Laura; Martín, Teresa; Pedraza, Manuela; Carnero, Beatriz; Guardeño, Raquel; Verdaguer, Helena; Mut, Alejandro; Vilanova, David; Garcia, Adelaida |